185 related articles for article (PubMed ID: 34128720)
21. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.
Radbruch A; Weberling LD; Kieslich PJ; Eidel O; Burth S; Kickingereder P; Heiland S; Wick W; Schlemmer HP; Bendszus M
Radiology; 2015 Jun; 275(3):783-91. PubMed ID: 25848905
[TBL] [Abstract][Full Text] [Related]
22. Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats.
Bussi S; Coppo A; Botteron C; Fraimbault V; Fanizzi A; De Laurentiis E; Colombo Serra S; Kirchin MA; Tedoldi F; Maisano F
J Magn Reson Imaging; 2018 Mar; 47(3):746-752. PubMed ID: 28730643
[TBL] [Abstract][Full Text] [Related]
23. Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
McDonald JS; Hunt CH; Kolbe AB; Schmitz JJ; Hartman RP; Maddox DE; Kallmes DF; McDonald RJ
Radiology; 2019 Sep; 292(3):620-627. PubMed ID: 31264948
[TBL] [Abstract][Full Text] [Related]
24. Neurologic Effects of Gadolinium Retention in the Brain after Gadolinium-based Contrast Agent Administration.
Ayers-Ringler J; McDonald JS; Connors MA; Fisher CR; Han S; Jakaitis DR; Scherer B; Tutor G; Wininger KM; Dai D; Choi DS; Salisbury JL; Jannetto PJ; Bornhorst JA; Kadirvel R; Kallmes DF; McDonald RJ
Radiology; 2022 Mar; 302(3):676-683. PubMed ID: 34931861
[TBL] [Abstract][Full Text] [Related]
25. Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study.
Tibussek D; Rademacher C; Caspers J; Turowski B; Schaper J; Antoch G; Klee D
Radiology; 2017 Oct; 285(1):223-230. PubMed ID: 28640695
[TBL] [Abstract][Full Text] [Related]
26. Signal changes in enhanced T1-weighted images related to gadolinium retention: A three-time-point imaging study.
Lersy F; Diepenbroek AL; Lamy J; Willaume T; Bierry G; Cotton F; Kremer S
J Neuroradiol; 2021 Mar; 48(2):82-87. PubMed ID: 32615207
[TBL] [Abstract][Full Text] [Related]
27. Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation.
Stanescu AL; Shaw DW; Murata N; Murata K; Rutledge JC; Maloney E; Maravilla KR
Pediatr Radiol; 2020 Mar; 50(3):388-396. PubMed ID: 31989188
[TBL] [Abstract][Full Text] [Related]
28. Gadolinium Retention in the Central and Peripheral Nervous System: Implications for Pain, Cognition, and Neurogenesis.
Alkhunizi SM; Fakhoury M; Abou-Kheir W; Lawand N
Radiology; 2020 Nov; 297(2):407-416. PubMed ID: 32808889
[TBL] [Abstract][Full Text] [Related]
29. Gadolinium Tissue Distribution in a Large-Animal Model after a Single Dose of Gadolinium-based Contrast Agents.
Richter H; Bücker P; Martin LF; Dunker C; Fingerhut S; Xia A; Karol A; Sperling M; Karst U; Radbruch A; Jeibmann A
Radiology; 2021 Dec; 301(3):637-642. PubMed ID: 34546128
[TBL] [Abstract][Full Text] [Related]
30. Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to rats.
Bussi S; Coppo A; Bonafè R; Rossi S; Colombo Serra S; Penard L; Kirchin MA; Maisano F; Tedoldi F
J Magn Reson Imaging; 2021 Nov; 54(5):1636-1644. PubMed ID: 33973290
[TBL] [Abstract][Full Text] [Related]
31. Speciation Analysis of Gadolinium in the Water-Insoluble Rat Brain Fraction After Administration of Gadolinium-Based Contrast Agents.
Strzeminska I; Factor C; Robert P; Szpunar J; Corot C; Lobinski R
Invest Radiol; 2021 Sep; 56(9):535-544. PubMed ID: 33813574
[TBL] [Abstract][Full Text] [Related]
32. Comparative study between gadobenate dimeglumine and gadobutrol in rats with brain ischemia: evaluation of somatosensory evoked potentials.
Frigeni V; Miragoli L; Grotti And A; Lorusso V
Invest Radiol; 2001 Oct; 36(10):561-72. PubMed ID: 11577266
[TBL] [Abstract][Full Text] [Related]
33. Dentate Nucleus Signal Intensity Increases Following Repeated Gadobenate Dimeglumine Administrations: A Retrospective Analysis.
Nguyen NC; Molnar TT; Cummin LG; Kanal E
Radiology; 2020 Jul; 296(1):122-130. PubMed ID: 32343210
[TBL] [Abstract][Full Text] [Related]
34. Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration.
Weberling LD; Kieslich PJ; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Radbruch A
Invest Radiol; 2015 Nov; 50(11):743-8. PubMed ID: 26352749
[TBL] [Abstract][Full Text] [Related]
35. Elemental Bioimaging of Sheep Bone and Articular Cartilage After Single Application of Gadolinium-Based Contrast Agents.
Richter H; Verlemann C; Jeibmann A; Martin LF; Luebke AM; Karol A; Sperling M; Radbruch A; Karst U
Invest Radiol; 2024 Apr; 59(4):287-292. PubMed ID: 37747456
[TBL] [Abstract][Full Text] [Related]
36. Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents.
Kiviniemi A; Gardberg M; Ek P; Frantzén J; Bobacka J; Minn H
Neuroradiology; 2019 May; 61(5):535-544. PubMed ID: 30710184
[TBL] [Abstract][Full Text] [Related]
37. Effect of at Least 10 Serial Gadobutrol Administrations on Brain Signal Intensity Ratios on T1-Weighted MRI in Children: A Matched Case-Control Study.
Ozturk K; Nascene D
AJR Am J Roentgenol; 2021 Sep; 217(3):753-760. PubMed ID: 33112200
[No Abstract] [Full Text] [Related]
38. Gadolinium-based Contrast Agent Biodistribution and Speciation in Rats.
Le Fur M; Moon BF; Zhou IY; Zygmont S; Boice A; Rotile NJ; Ay I; Pantazopoulos P; Feldman AS; Rosales IA; How IDAL; Izquierdo-Garcia D; Hariri LP; Astashkin AV; Jackson BP; Caravan P
Radiology; 2023 Oct; 309(1):e230984. PubMed ID: 37874235
[TBL] [Abstract][Full Text] [Related]
39. Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats.
Fretellier N; Granottier A; Rasschaert M; Grindel AL; Baudimont F; Robert P; Idée JM; Corot C
Invest Radiol; 2019 Feb; 54(2):61-71. PubMed ID: 30394964
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and tissue distribution in animals of gadobenate ion, the magnetic resonance imaging contrast enhancing component of gadobenate dimeglumine 0.5 M solution for injection (MultiHance).
Lorusso V; Arbughi T; Tirone P; de Haën C
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S181-94. PubMed ID: 10608414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
